Effect of human natural xenoantibody depletion and complement inactivation on early pig kidney function

Experimental Nephrology

Volumn 7, Issue 3, 1999, Pages 217-228

  Cruzado, Josep M ^a   Torras, Joan ^a   Riera, Marta ^a   Condom, Enric ^a   Lloberas, Nüria ^a   Herrero, Immaculada ^a   Martorell, Jaume ^b   Grinyó, Josep M ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Complement; Hyperacute xenograft rejection; Kidney xenoperfusion; Natural xenoreactive antibodies; P selectin; Platelet activating factor

Indexed keywords

ANTIBODY; COMPLEMENT COMPONENT C1S INHIBITOR; PADGEM PROTEIN; THROMBOCYTE ACTIVATING FACTOR;

ANIMAL TISSUE; ARTICLE; COMPLEMENT INHIBITION; FUNCTIONAL ASSESSMENT; GLOMERULUS FILTRATION RATE; GRAFT REJECTION; HISTOPATHOLOGY; IMMUNOGENICITY; KIDNEY FUNCTION; KIDNEY PERFUSION; MORPHOLOGY; NONHUMAN; PRIORITY JOURNAL; SWINE; XENOGRAFT;

EID: 0033035498     PISSN: 10187782     EISSN: None     Source Type: Journal    
DOI: 10.1159/000020605     Document Type: Article

References (51)

1. Platt JL, Vercellotti GM, Dalmasso AP, Matas AJ, Bolman RM, Najarian JS, Bach FH: Transplantation of discordant xenografts: A review of progress. Immunol Today 1990; 11:450-457.
2. Calne RY: Organ transplantation between widely disparate species. Transplant Proc 1970;2:550-556.
3. Platt JL: Hyperacute Xenograft Rejection. Austin, Landes, 1995.
4. Platt JL: Xenotransplantation: recent progress and current perspectives. Curr Opin Immunol 1996;8:721-728.
5. Good AH, Cooper DKC, Malcolm AJ, Ippolito RM, Koren E, Neethling FA, Ye Y, Kuhdi N, Lamontagne LR: Identification of carbohydrate structures that bind human antiporcine antibodies: Implications for discordant xenografting in humans. Transplant Proc 1992;24: 559-562.
6. Sandrin MS, Vaughan HA, Dabkowski PL, McKenzie IFC: Antipig IgM antibodies in human serum react predominantly with Galα(1, 3)Gal epitopes. Proc Natl Acad Sci USA 1993; 90:11391-11395.
7. Galili U, Macher BA, Buehler J, Shohet SB: Human natural anti-α-galactosyl IgG: The specific recognition of α(1-3)-linked galactose residues. J Exp Med 1985;162:573-582.
8. Galili U, Swanson K: Gene sequences suggest inactivation of α-1,3-galactosyltransferase in catarrhines after the divergence of apes from monkeys. Proc Natl Acad Sci USA 1991;88: 7401-7404.
9. Daniels LJ, Platt JL: Hyperacute xenograft rejection as an immunologic barrier to xenotransplantation. Kidney Int 1997;51(suppl 58):28-35.
10. Saadi S, Platt JL: Transient perturbation of endothelial integrity induced by natural antibodies and complement. J Exp Med 1995;181: 21-31.
11. Sandrin MS, Fodor WL, Mouhtouris E, Osman N, Cohrey S, Rollins SA, Guilmette ER, Setter E, Squintos P, McKenzie IF: Enzymatic remodeling of the carbohydrate surface of a xenogenic cell substantially reduces human antibody binding and complement-mediated cytolysis. Nat Med 1995;1:1261-1267.
12. Sharma A, Okabe J, Birch P, McClellan SB, Martin MJ, Platt JL, Logan JS: Reduction in the level of Gal(alpha1,3)Gal in transgenic mice and pigs by the expression of an alpha(1, 2)fucosyltransferase. Proc Natl Acad Sci USA 1996;93:7190-7195.
13. Cozzi E, White D: The generation of transgenic pigs as potential donors for humans. Nat Med 1995;1:964-966.
14. Ryan US: Complement inhibitory therapeutics and xenotransplantation. Nat Med 1995;1: 967-968.
15. Bach FH, Winkler H, Ferran C, Hancock WW, Robson SC: Delayed xenograft rejection. Immunol Today 1996;17:379-384.
16. Hancock WW: Beyond hyperacute rejection: Strategies for development of pig-primate xenotransplantation. Kidney Int 1997;51(suppl 58):36-40.
17. Lawson JH, Platt FL: Molecular barriers to xenotransplantation. Transplantation 1996;62: 303-310.
18. Parker W, Saadi S, Lin SS, Holzknecht ZE, Bustos M, Platt JL: Transplantation of discordant xenografts: A challenge revisited. Immunol Today 1996;17:373-378.
19. Suckfüll MM, Pieske O, Müdsam M, Babic R, Hammer C: The contribution of endothelial cells to hyperacute rejection in xenogeneic perfused working hearts. Transplantation 1994; 57:262-267.
20. Maack T: Physiological evaluation of the isolated perfused rat kidney. Am J Physiol 1980; 238:F71-F78.
21. Herrero I, Torras J, Carrera M, Castells A, Pasto L, Gil-Vernet S, Alsina J, Grinyo JM: Evaluation of a preservation solution containing fructose-1,6-diphosphate and mannitol using the isolated perfused rat kidney. Nephrol Dial Transplant 1995;10:519-526.
22. Pierson RN, Kasper-Konig W, Twe DN, Young UK. Dunning JJ, Horsley J, Carey NR, Wallwork J, White DJ: Hyperacute lung rejection in a pig-to-human transplant model: The role of anti-pig antibody and complement. Transplantation 1997;63:594-603.
23. Bligh EG, Dyer WJ: A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959;37:911-917.
24. Ferraris L, Karmeli F, Eliakim R, Klein J, Fiocchi C, Rachmilewitz D: Intestinal epithelial cells contribute to the enhanced generation of platelet activating factor in ulcerative colitis. Gut 1993;34:665-668.
25. Bradley PP, Priebat DA, Christensen RD, Rothstein RD: Measurement of cutaneous inflammation: Estimation of neutrophil content with an enzyme marker. J Invest Dermatol 1982;78:206-209.
26. Bussolino F, Camussi G, Aglietta M, Braquet P, Bosia A, Pescarmona G, Sanavio F, D'Urso N, Marchisio PC: Human endothelial cells are target for platelet activating factor: Platelet-activating factor induces changes in cytoskeleton structures. J Immunol 1987;139:2439-2446.
27. Bach FH, Robson SC, Winkler H, Ferran C, Stuhlmeier KM, Wrighton CJ, Hancock WW: Barriers to xenotransplantation. Nat Med 1995;1:869-873.
28. Sanfilippo F: Overcoming immunologic barriers to discordant organ xenotransplantation. Nephrol Dial Transplant 1996;11:1943-1945.
29. Byrne GW, McCurry KR, Martin MJ, McClellan SM, Platt JL, Logan JS: Transgenic pigs expressing human CD59 and decay-accelerating factor produce an intrinsic barrier to complement-mediated damage. Transplantation 1997;63:149-155.
30. Taniguchi S, Neethling FA, Korchagina EY, Bovin N, Ye Y, Kobayashi T, Niekrasz M, Li S, Koren E, Oriol R, Cooper DK: In vivo immunoadsorption of antipig antibodies in baboons using a specific Galα1-3Gal column. Transplantation 1996;62:1379-1384.
31. Lawson JH, Diamond LE, Martin MJ, Hoopes CW, Weidner BC, Lin SS, Daniels LJ, Harland RC, Bollinger RR, Logan J, Platt JL: Expression of human complement regulatory proteins CD59 and DAF prolongs graft survival and physiologic function in pig-to-baboon kidney transplantation (abstract). 4th Int Congrof Xenotransplantation, Nantes 1997.
32. Grinyo JM, Cruzado JM, Riera M, Martorell J, Condom E, Borobia FG, Muñoz J, Herrero I, Lloberas N, Gimeno A, Alsina J, Torras J: Functional and pathologic outcome after complement inactivation in a pig kidney-human blood xenoperfusion model. Transplant Proc 1997;29:2318-2321.
33. Palmetshofer A, Galili U, Dalmasso AP, Robson SC, Bach FH: Alpha-galactosyl epitope-mediated activation of porcine aortic endothelial cells. Transplantation 1998;65:844-853.
34. Holzknecht ZE, Platt JL: Identification of porcine endothelial cell membrane antigens recognized by human xenoreactive natural antibodies. J Immunol 1995;154:4565-4575.
35. Leventhal JR, Sakiyalak P, Witson J, Simone P, Matas AJ, Bolman RM, Dalmasso AP: The synergistic effect of combined antibody and complement depletion on discordant cardiac xenograft survival in nonhuman primates. Transplantation 1993;57:974-978.
36. Hattori R, Hamilton KK, Fugate RD, McEver RP, Sims PJ: Stimulated secretion of endothelial von Willebrand factor is accompanied by rapid redistribution to the cell surface of the intracellular granule membrane protein GMP-140. J Biol Chem 1989;264:7768-7771.
37. Zimmerman GA, Prescott SM, McIntyre TM: Endothelial cell interactions with granulocytes: Tethering and signaling molecules. Immunol Today 1992;13:93-100.
38. Coughlan AF, Berndt MC, Dunlop LC, Handcock WW: In vivo studies of P-selectin and platelet activating factor during endotoxemia, accelerated allograft rejection and discordant xenograft rejection. Transplant Proc 1993;25: 2930-2931.
39. Foreman KE, Vaporciyan AA, Bonish BK, Jones ML, Johnson KJ, Glovsky MM, Eddy SM, Ward PA: C5a-induced expression of P-selectin in endothelial cells. J Clin Invest 1994; 94:1147-1155.
40. Peerschke EIB, Reid KBM, Ghebrehiwet B: Platelet activation by C1q results in the induction of alpha IIb/beta 3 integrins (GP IIb-IIIa) and the expression of P-selectin and procoagulant activity. J Exp Med 1993;178:579-587.
41. Hattori R, Hamilton KK, McEver RP, Sims PJ: Complement proteins C5b-C9 induce secretion of high molecular weight multimers of endothelial von Willebrand factor and translocation of granule membrane protein GMP-140 to the cell surface. J Biol Chem 1989;264: 9053-9060.
42. Imaizumi TA, Stafforini DM, Yamada Y, McIntyre TM, Prescott SM, Zimmerman GA: Platelet-activating factor: A mediator for clinicians. J Intern Med 1995;238:5-20.
43. Lorant DE, Topham MK, Whatley RE, McEver RP, McIntyre TM, Prescott SM, Zimmerman GA: Inflammatory roles of P-selectin. J Clin Invest 1993;92:559-570.
44. Blann AD, Lip GYH: Hypothesis: Is soluble P-selectin a new marker of platelet activation? Atherosclerosis 1997;128:135-138.
45. Morigi M, Zoja C, Colleoni S, Angioletti S, Imberti B, Remuzzi A, Remuzzi G: Xenogeneic human serum promotes leukocyte adhesion to porcine endothelium under flow conditions, possibly through the activation of the transcription factor NF-kB. Xenotransplantation 1998; 5:57-60.
46. Kravchenko VV, Pan Z, Han J, Herbert JM, Ulevitch RJ, Ye RD: Platelet-activating factor induces NF-kB activation through a G protein-coupled pathway. J Biol Chem 1995;270: 14928-14934.
47. Makowka L, Miller C, Chapchap P, Podesta L, Pan C, Pressley D, Mazzaferro V, Esquivel CO, Todo S, Banner B: Prolongation of pig to dog renal xenograft by modification of the inflammatory mediator response. Ann Surg 1987;206: 482-495.
48. Cruzado JM, Torras J, Riera M, Lloberas N, Herrero I, Condom E, Martorell J. Alsina J, Grinyo JM: Effect of a platelet-activating factor receptor antagonist on hyperacute xenograft rejection: Evaluation in a pig kidney-human blood xenoperfusion model. Clin Exp Immunol 1998;113:136-144.
49. Kroll MH, Harris TS, Moake JL, Handin RI, Schafer AI: Von Willebrand factor binding to platelet GpIb initiates signals for platelet activation. J Clin Invest 1991;88:1568-1573.
50. Marquet RL, van Overdam KA, van Rooijen N. de Bruin RWF, Ijzermans JNM: Delayed xenograft rejection is not mitigated by depletion of macrophages and NK cells (abstract). 4th Int Congr of Xenotransplantation, Nantes 1997.
51. Weyrich AS, McIntyre TM, McEver RP, Prescott SM, Zimmerman GA: Monocyte tethering by P-selectin regulates monocyte chemotactic protein-1 and tumor necrosis factor-α secretion. J Clin Invest 1995;95:2297-2303.